Dimitrios C. Mastellos

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

'Complement-ing' tissue inflammation via granzyme K?

'Complement-ing' tissue inflammation via granzyme K?

Journal: Nature immunology

Published: April 04, 2025

Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19.

Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19.

Journal: Immunology

Published: December 09, 2024

Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy.

Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy.

Journal: Trends in pharmacological sciences

Published: September 04, 2024

Synthesis and Evaluation of 99mTc(CO)3 Complexes with Ciprofloxacin Dithiocarbamate for Infection Imaging.

Synthesis and Evaluation of 99mTc(CO)3 Complexes with Ciprofloxacin Dithiocarbamate for Infection Imaging.

Journal: Pharmaceutics

Published: August 09, 2024

A guide to complement biology, pathology and therapeutic opportunity.

A guide to complement biology, pathology and therapeutic opportunity.

Journal: Nature reviews. Immunology

Published: July 20, 2023

A High-Performance Antibacterial Nanostructured ZnO Microfluidic Device for Controlled Bacterial Lysis and DNA Release.

A High-Performance Antibacterial Nanostructured ZnO Microfluidic Device for Controlled Bacterial Lysis and DNA Release.

Journal: Antibiotics (Basel, Switzerland)

Published: June 15, 2023

The Complement-Targeted Inhibitor Mini-FH Protects against Experimental Periodontitis via Both C3-Dependent and C3-Independent Mechanisms.

The Complement-Targeted Inhibitor Mini-FH Protects against Experimental Periodontitis via Both C3-Dependent and C3-Independent Mechanisms.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: April 04, 2023

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.

Journal: Science advances

Published: August 17, 2022

Recent developments in C3-targeted complement therapeutics.

Recent developments in C3-targeted complement therapeutics.

Journal: Seminars in immunology

Published: August 01, 2022

Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde.

Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde.

Journal: Seminars in immunology

Published: July 19, 2022

Emerging opportunities for C3 inhibition in the eye.

Emerging opportunities for C3 inhibition in the eye.

Journal: Seminars in immunology

Published: July 05, 2022

C3-targeted host-modulation approaches to oral inflammatory conditions.

C3-targeted host-modulation approaches to oral inflammatory conditions.

Journal: Seminars in immunology

Published: June 12, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026